SCHEMBL8529481

SCHEMBL8529481

COc1nc(N)nc2c1ncn2[C@@H]1O[C@H](COC(=O)C(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HINT1 P49773 3/20 0.45
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
NT5E P21589 4/20 0.39
SLC29A1 Q99808 3/20 0.38
CYP2C19 P33261 1/20 0.37
HSP90B1 P14625 1/20 0.37
ADORA3 P0DMS8 3/20 0.36
ADORA1 P30542 2/20 0.36
ADORA2B P29275 2/20 0.36
ADORA2A P29274 1/20 0.36
MARS1 P56192 1/20 0.36
CD99 P14209 1/20 0.35
DNMT1 P26358 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8533343 0.87 HINT1 (0.40) HINT1ALDH1A1LMNATP53MAPT
SCHEMBL8529066 0.86 CYP2C19 (0.48) SLC29A1CYP2C19ADORA3ADORA1ADORA2B
SCHEMBL8529436 0.84 ALDH1A1 (0.48) HINT1ALDH1A1LMNATP53MAPT
SCHEMBL8533171 0.84 HINT1 (0.40) HINT1ALDH1A1LMNATP53MAPT
SCHEMBL8529887 0.84 HINT1 (0.40) HINT1ALDH1A1LMNATP53MAPT
SCHEMBL8529428 0.83 HINT1 (0.61) HINT1NT5ESLC29A1CYP2C19ADORA3
SCHEMBL8528882 0.81 HINT1 (0.45) HINT1NT5ESLC29A1CYP2C19ADORA3
SCHEMBL8529223 0.81 HINT1 (0.45) HINT1NT5ESLC29A1CYP2C19HSP90B1
SCHEMBL8988189 0.81 HINT1 (0.38) HINT1ALDH1A1LMNATP53MAPT
SCHEMBL8530537 0.80 P2RX3 (0.46) HINT1ALDH1A1LMNATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5821236-A Tumor treatment with arabinofuranosyl purine derivatives GLAXO WELLCOME INC. (US) 1998-10-13 US disclosed
US-5747472-A ANTICARCINOGENIC AGENTS AND ANTITUMOR AGENTS GLAXO WELLCOME INC. (US) 1998-05-05 US disclosed
US-5492897-A ANTITUMOR AGENTS, AUTOIMMUNE DISEASES BURROUGHS WELLCOME CO. (141) (US) 1996-02-20 US disclosed
WO-1992001456-A1 HETEROCYCLIC COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1992-02-06 WO disclosed